Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Microsoft
MSFT
|
+$8.69B |
| 2 |
Apple
AAPL
|
+$6.87B |
| 3 |
Amazon
AMZN
|
+$6.62B |
| 4 |
Meta Platforms (Facebook)
META
|
+$4.26B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
Top Sells
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$143M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$40.8M |
| 3 |
Nuveen ESG Large-Cap Value ETF
NULV
|
+$22M |
| 4 |
Nuveen ESG Small-Cap ETF
NUSC
|
+$20.8M |
| 5 |
Nuveen ESG Large-Cap Growth ETF
NULG
|
+$19.2M |
Sector Composition
| 1 | Technology | 18.98% |
| 2 | Financials | 14.46% |
| 3 | Healthcare | 12.78% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Amneal Pharmaceuticals
AMRX
$3.14B
| $2.51M | ﹤0.01% |
+349,348
| New | +$2.51M |
|
|
ACBI
2327
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $2.5M | ﹤0.01% |
+146,245
| New | +$2.5M |
|
|
FFG
2328
DELISTED
FBL Financial Group
FFG
| $2.5M | ﹤0.01% |
+39,164
| New | +$2.5M |
|
|
OMN
2329
DELISTED
OMNOVA Solutions Inc.
OMN
| $2.49M | ﹤0.01% |
+399,960
| New | +$2.49M |
|
2330
Funko
FNKO
$182M
| $2.49M | ﹤0.01% |
+102,867
| New | +$2.49M |
|
|
PFC
2331
DELISTED
Premier Financial Corp. Common Stock
PFC
| $2.49M | ﹤0.01% |
+87,170
| New | +$2.49M |
|
2332
Berry Corp
BRY
$257M
| $2.48M | ﹤0.01% |
+234,035
| New | +$2.48M |
|
|
STFC
2333
DELISTED
State Auto Financial Corp
STFC
| $2.48M | ﹤0.01% |
+70,801
| New | +$2.48M |
|
2334
WPP
WPP
$5.86B
| $2.48M | ﹤0.01% |
39,367
+31,741
| +416% | +$2M |
|
2335
Bally's
BALY
$487M
| $2.47M | ﹤0.01% |
+83,032
| New | +$2.47M |
|
2336
ATN International
ATNI
$238M
| $2.46M | ﹤0.01% |
+42,666
| New | +$2.46M |
|
2337
Resources Connection
RGP
$172M
| $2.46M | ﹤0.01% |
+153,804
| New | +$2.46M |
|
|
CBAY
2338
DELISTED
Cymabay Therapeutics
CBAY
| $2.46M | ﹤0.01% |
+344,046
| New | +$2.46M |
|
2339
Weis Markets
WMK
$1.75B
| $2.46M | ﹤0.01% |
+67,472
| New | +$2.46M |
|
|
LDL
2340
DELISTED
Lydall, Inc.
LDL
| $2.46M | ﹤0.01% |
+121,562
| New | +$2.46M |
|
|
EGRX
2341
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.45M | ﹤0.01% |
+44,068
| New | +$2.45M |
|
2342
TruBridge
TBRG
$302M
| $2.44M | ﹤0.01% |
+87,671
| New | +$2.44M |
|
2343
Lennar Class B
LEN.B
$34B
| $2.44M | ﹤0.01% |
+66,511
| New | +$2.44M |
|
|
GTT
2344
DELISTED
GTT Communications, Inc.
GTT
| $2.42M | ﹤0.01% |
+137,425
| New | +$2.42M |
|
2345
Intellia Therapeutics
NTLA
$1.23B
| $2.42M | ﹤0.01% |
+147,585
| New | +$2.42M |
|
2346
Smith & Wesson
SWBI
$415M
| $2.4M | ﹤0.01% |
+346,233
| New | +$2.4M |
|
|
NPTN
2347
DELISTED
NEOPHOTONICS CORP
NPTN
| $2.4M | ﹤0.01% |
+573,621
| New | +$2.4M |
|
2348
Precigen
PGEN
$1.13B
| $2.39M | ﹤0.01% |
+312,350
| New | +$2.39M |
|
|
DF
2349
DELISTED
Dean Foods Company
DF
| $2.39M | ﹤0.01% |
+2,586,034
| New | +$2.39M |
|
|
JMIA
2350
Jumia Technologies
JMIA
$1.21B
| $2.38M | ﹤0.01% |
+89,958
| New | +$2.38M |
|